Industry: Medical Devices & Consumables
Published Date: 2025-02-07
Pages: 77 Pages
Report ld: 3422743
Request Sample
Customized Report
CRM197 Market Size(US$)

CAGR 2025-2031
5.3%
Market Size,2031
USD 264
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for CRM197 was valued at US$ 185 million in the year 2024 and is projected to reach a revised size of US$ 264 million by 2031, growing at a CAGR of 5.3% during the forecast period.
CRM197 is a non-toxic mutant of diphtheria toxin and it"s widely used as a carrier protein for conjugate vaccines.
Pfizer Inc is one of the most important global manufacturers of CRM197, holds a share of over 85%. North America is the largest market, occupied for over 75%. In terms of type, research grade is the largest segment, with a share of over 85%. And in terms of application, pneumococcal conjugate vaccine segment holds a share of about 90%.
This report aims to provide a comprehensive presentation of the global market for CRM197, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CRM197.
The CRM197 market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global CRM197 market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CRM197 companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CRM197 company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CRM197 Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Research Grade CRM197
1.2.3 cGMP Grade CRM197
1.3 Market by Application
1.3.1 Global CRM197 Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pneumococcal Conjugate Vaccine
1.3.3 Meningococcal Polysaccharide Conjugate Vaccine
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global CRM197 Market Perspective (2020-2031)
2.2 Global CRM197 Growth Trends by Region
2.2.1 Global CRM197 Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 CRM197 Historic Market Size by Region (2020-2025)
2.2.3 CRM197 Forecasted Market Size by Region (2026-2031)
2.3 CRM197 Market Dynamics
2.3.1 CRM197 Industry Trends
2.3.2 CRM197 Market Drivers
2.3.3 CRM197 Market Challenges
2.3.4 CRM197 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CRM197 Players by Revenue
3.1.1 Global Top CRM197 Players by Revenue (2020-2025)
3.1.2 Global CRM197 Revenue Market Share by Players (2020-2025)
3.2 Global CRM197 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by CRM197 Revenue
3.4 Global CRM197 Market Concentration Ratio
3.4.1 Global CRM197 Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CRM197 Revenue in 2024
3.5 Global Key Players of CRM197 Head office and Area Served
3.6 Global Key Players of CRM197, Product and Application
3.7 Global Key Players of CRM197, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 CRM197 Breakdown Data by Type
4.1 Global CRM197 Historic Market Size by Type (2020-2025)
4.2 Global CRM197 Forecasted Market Size by Type (2026-2031)
5 CRM197 Breakdown Data by Application
5.1 Global CRM197 Historic Market Size by Application (2020-2025)
5.2 Global CRM197 Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America CRM197 Market Size (2020-2031)
6.2 North America CRM197 Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America CRM197 Market Size by Country (2020-2025)
6.4 North America CRM197 Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CRM197 Market Size (2020-2031)
7.2 Europe CRM197 Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe CRM197 Market Size by Country (2020-2025)
7.4 Europe CRM197 Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific CRM197 Market Size (2020-2031)
8.2 Asia-Pacific CRM197 Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific CRM197 Market Size by Region (2020-2025)
8.4 Asia-Pacific CRM197 Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America CRM197 Market Size (2020-2031)
9.2 Latin America CRM197 Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America CRM197 Market Size by Country (2020-2025)
9.4 Latin America CRM197 Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CRM197 Market Size (2020-2031)
10.2 Middle East & Africa CRM197 Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa CRM197 Market Size by Country (2020-2025)
10.4 Middle East & Africa CRM197 Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer Inc.
11.1.1 Pfizer Inc. Company Details
11.1.2 Pfizer Inc. Business Overview
11.1.3 Pfizer Inc. CRM197 Introduction
11.1.4 Pfizer Inc. Revenue in CRM197 Business (2020-2025)
11.1.5 Pfizer Inc. Recent Development
11.2 Ligand Pharmaceuticals
11.2.1 Ligand Pharmaceuticals Company Details
11.2.2 Ligand Pharmaceuticals Business Overview
11.2.3 Ligand Pharmaceuticals CRM197 Introduction
11.2.4 Ligand Pharmaceuticals Revenue in CRM197 Business (2020-2025)
11.2.5 Ligand Pharmaceuticals Recent Development
11.3 CanSino Biologic
11.3.1 CanSino Biologic Company Details
11.3.2 CanSino Biologic Business Overview
11.3.3 CanSino Biologic CRM197 Introduction
11.3.4 CanSino Biologic Revenue in CRM197 Business (2020-2025)
11.3.5 CanSino Biologic Recent Development
11.4 Beijing Kexing Biology Product
11.4.1 Beijing Kexing Biology Product Company Details
11.4.2 Beijing Kexing Biology Product Business Overview
11.4.3 Beijing Kexing Biology Product CRM197 Introduction
11.4.4 Beijing Kexing Biology Product Revenue in CRM197 Business (2020-2025)
11.4.5 Beijing Kexing Biology Product Recent Development
11.5 Scarab Genomics
11.5.1 Scarab Genomics Company Details
11.5.2 Scarab Genomics Business Overview
11.5.3 Scarab Genomics CRM197 Introduction
11.5.4 Scarab Genomics Revenue in CRM197 Business (2020-2025)
11.5.5 Scarab Genomics Recent Development
11.6 Xpress Biologics
11.6.1 Xpress Biologics Company Details
11.6.2 Xpress Biologics Business Overview
11.6.3 Xpress Biologics CRM197 Introduction
11.6.4 Xpress Biologics Revenue in CRM197 Business (2020-2025)
11.6.5 Xpress Biologics Recent Development
11.7 Fina Biosolutions
11.7.1 Fina Biosolutions Company Details
11.7.2 Fina Biosolutions Business Overview
11.7.3 Fina Biosolutions CRM197 Introduction
11.7.4 Fina Biosolutions Revenue in CRM197 Business (2020-2025)
11.7.5 Fina Biosolutions Recent Development
11.8 Eubiologics
11.8.1 Eubiologics Company Details
11.8.2 Eubiologics Business Overview
11.8.3 Eubiologics CRM197 Introduction
11.8.4 Eubiologics Revenue in CRM197 Business (2020-2025)
11.8.5 Eubiologics Recent Development
11.9 EirGenix Inc.
11.9.1 EirGenix Inc. Company Details
11.9.2 EirGenix Inc. Business Overview
11.9.3 EirGenix Inc. CRM197 Introduction
11.9.4 EirGenix Inc. Revenue in CRM197 Business (2020-2025)
11.9.5 EirGenix Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global CRM197 market size was US$ 194 million in 2025 and is forecast to reach a readjusted size of US$ 277 million by 2032 with a CAGR of 5.3% during the forecast period 2026-2032.
Published Date: 2026-01-05
Pages: 79
USD 4250.00
(Single User License)
The global CRM197 market was valued at US$ 194 million in 2025 and is anticipated to reach US$ 277 million by 2032, at a CAGR of 5.3% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 110
USD 2900.00
(Single User License)
The global market for CRM197 was estimated to be worth US$ 194 million in 2025 and is projected to reach US$ 277 million, growing at a CAGR of 5.3% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 92
USD 3950.00
(Single User License)
The global CRM197 market size was US$ 185 million in 2024 and is forecast to a readjusted size of US$ 264 million by 2031 with a CAGR of 5.3% during the forecast period 2025-2031.
Published Date: 2025-09-10
Pages: 77
USD 4250.00
(Single User License)
The global CRM197 market is projected to grow from US$ 185 million in 2024 to US$ 264 million by 2031, at a CAGR of 5.3% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-07-31
Pages: 124
USD 4900.00
(Single User License)
The global market for CRM197 was estimated to be worth US$ 185 million in 2024 and is forecast to a readjusted size of US$ 264 million by 2031 with a CAGR of 5.3% during the forecast period 2025-2031.
Published Date: 2025-02-07
Pages: 92
USD 3950.00
(Single User License)
CRM197 is a non-toxic mutant of diphtheria toxin and it's widely used as a carrier protein for conjugate vaccines.
Published Date: 2024-01-18
Pages: 97
USD 3950.00
(Single User License)
CRM197 is a non-toxic mutant of diphtheria toxin and it's widely used as a carrier protein for conjugate vaccines.
Published Date: 2024-01-03
Pages: 74
USD 2900.00
(Single User License)
The global CRM197 market size was US$ 194 million in 2025 and is forecast to reach a readjusted size of US$ 277 million by 2032 with a CAGR of 5.3% during the forecast period 2026-2032.
Published: 2026-01-05
Pages: 79
The global CRM197 market was valued at US$ 194 million in 2025 and is anticipated to reach US$ 277 million by 2032, at a CAGR of 5.3% from 2026 to 2032.
Published: 2026-01-05
Pages: 110
The global market for CRM197 was estimated to be worth US$ 194 million in 2025 and is projected to reach US$ 277 million, growing at a CAGR of 5.3% from 2026 to 2032.
Published: 2026-01-05
Pages: 92
The global CRM197 market size was US$ 185 million in 2024 and is forecast to a readjusted size of US$ 264 million by 2031 with a CAGR of 5.3% during the forecast period 2025-2031.
Published: 2025-09-10
Pages: 77
The global CRM197 market is projected to grow from US$ 185 million in 2024 to US$ 264 million by 2031, at a CAGR of 5.3% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-07-31
Pages: 124
The global market for CRM197 was estimated to be worth US$ 185 million in 2024 and is forecast to a readjusted size of US$ 264 million by 2031 with a CAGR of 5.3% during the forecast period 2025-2031.
Published: 2025-02-07
Pages: 92
CRM197 is a non-toxic mutant of diphtheria toxin and it's widely used as a carrier protein for conjugate vaccines.
Published: 2024-01-18
Pages: 97
CRM197 is a non-toxic mutant of diphtheria toxin and it's widely used as a carrier protein for conjugate vaccines.
Published: 2024-01-03
Pages: 74
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now